Distribution of Human T-Lymphotropic Virus (HTLV) and Hepatitis C Co-infection in Bahia, Brazil
Felicidade Mota Pereira, Maria da Conceição Chagas de Almeida, Fred Luciano Neves Santos, Roberto Perez Carreiro, Bernardo Galvão-Castro, Maria Fernanda Rios Grassi, Felicidade Mota Pereira, Maria da Conceição Chagas de Almeida, Fred Luciano Neves Santos, Roberto Perez Carreiro, Bernardo Galvão-Castro, Maria Fernanda Rios Grassi
Abstract
Both Human T-lymphotropic virus type 1 (HTLV-1) and hepatitis C virus (HCV) are endemic in Brazil. In Salvador, the capital of the state of Bahia, 2% and 1.5% of the general population is infected with HTLV-1 or HCV. This study aimed to estimate the prevalence and the distribution of HTLV/HCV coinfection in Bahia. This cross-sectional study was conducted at the Central Laboratory of Public Health for the state of Bahia (LACEN-BA). All samples in the LACEN database submitted to serological testing for anti-HCV (chemiluminescence) and anti-HTLV-1/2 (chemiluminescence/ELISA and Western blot) from 2004 to 2013 were included. Infection rate was expressed as the number of infected individuals per 100,000 inhabitants in a given municipality; municipalities were grouped by microregion for further analysis. A total of 120,192 samples originating from 358 of the 417 municipalities in Bahia (85.8%) were evaluated. The overall HCV coinfection rate in HTLV-positive was 14.31% [2.8 (ranging from 0.4 to 8.0) per 100,000 inhabitants.] Twenty-one (5%) of the municipalities reported at least one case of HTLV/HCV coinfection. Most cases (87%) were concentrated in three microregions (Salvador: 79%, Ilhéus/Itabuna: 5%, Porto Seguro: 3%). Coinfection occurred more frequently in males (51%) with a mean age of 59 [(IQR): 46-59] years. HTLV/HCV coinfection in the state of Bahia was more frequently found among males living in the microregions of Salvador, Ilhéus/Itabuna and Porto Seguro, all of which are known to be endemic for HTLV infection.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group. Arch Intern Med. 1991; 151: 2043–2048. 10.1001/archinte.1991.00400100115019 .
- Manns A, Wilks RJ, Murphy EL, Haynes G, Figueroa JP, Barnett M, et al. A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer. 1992; 51: 886–891. 10.1002/ijc.2910510609 .
- Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002; 36: S93–S98. 10.1053/jhep.2002.36389 .
- Nunes D, Boa-Sorte N, Grassi MF, Taylor GP, Teixeira MG, Barreto ML, et al. HTLV-1 is predominantly sexually transmitted in Salvador, the city with the highest HTLV-1 prevalence in Brazil. PLoS One. 2017; 12:e0171303 10.1371/journal.pone.0171303 .
- Bittencourt AL, Dourado I, Filho PB, Santos M, Valadao E, Alcantara LC, et al. Human T-cell lymphotropic virus type 1 infection among pregnant women in northeastern Brazil. J Acquir Immune Defic Syndr. 2001; 26: 490–494. 10.1097/00126334-200104150-00016 .
- Li HC, Biggar RJ, Miley WJ, Maloney EM, Cranston B, Hanchard B, et al. Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis. 2004; 190: 1275–1278. Epub 2004 Aug 30. 10.1086/423941 .
- Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012; 3: 388 10.3389/fmicb.2012.00388 .
- Catalan-Soares B, Carneiro-Proietti AB, Proietti FA, Interdisciplinary HRG. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saude Publica. 2005; 21: 926–931. Epub 2005 May 2. 10.1590/s0102-311x2005000300027 .
- Pereira FM, Almeida MC, Santos FL, Carreiro RP, Regis-Silva CG, Galvão-Castro B, et al. Evidence of new highly endemic clusters of human T-cell lymphotropic viral infection (HTLV) in Bahia, Brazil. Front Microbiol. 2019; 10: 1002 10.3389/fmicb.2019.01002 .
- Pereira LM, Martelli CM, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MR, et al. Prevalence and risk factors of Hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis. 2013; 13: 60 10.1186/1471-2334-13-60 .
- Zarife MA, Silva LK, Silva MB, Lopes GB, Barreto ML, Teixeira Mda G, et al. Prevalence of hepatitis C virus infection in north-eastern Brazil: a population-based study. Trans R Soc Trop Med Hyg. 2006; 100: 663–668. Epub 2005 Dec 28. 10.1016/j.trstmh.2005.09.009 .
- Nakashima K, Hayashi J, Hirata M, Kashiwagi S, Eda F. Hepatitis C virus infection on Iki Island, Japan, an area endemic for human T-lymphotropic virus type-I. A preliminary study in patients at clinics or hospitals. J Epidemiol. 1994; 4: 17–23. 10.2188/jea.4.17.
- Ziaee M, Namaei MH, Azarkar G. The prevalence of HTLV-1 and its co-Infection with HCV, HBV and HIV in hemophilic patients. Pak J Med Sci. 2015; 31: 1246–1249. 10.12669/pjms.315.7888 .
- Prasetyo AA, Dirgahayu P, Sari Y, Hudiyono H, Kageyama S. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia. J Infect Dev Ctries. 2013; 7: 453–467. 10.3855/jidc.2965 .
- Boschi-Pinto C, Stuver S, Okayama A, Trichopoulos D, Orav EJ, Tsubouchi H, et al. A follow-up study of morbidity and mortality associated with hepatitis C virus infection and its interaction with human T lymphotropic virus type I in Miyazaki, Japan. J Infect Dis. 2000; 181: 35–41. 10.1086/315177 .
- Ramos JM, Belda S, Reyes F, Rodriguez JC, Royo G, Gutierrez F. Prevalence of HIV, HBV, HCV, HTLV and Treponema pallidum among patients attending a rural hospital in Southern Ethiopia. J Clin Virol. 2012; 53: 268–269. Epub 2011 Dec 30. 10.1016/j.jcv.2011.12.004 .
- Vallejo A, Loza E, Mateos M. Absence of HTLV-1/2 infection among HCV- infected patients with no HIV-1/2 infection in Spain. J Clin Virol. 2015; 64: 72–73. Epub 2015 Jan 14. 10.1016/j.jcv.2015.01.010 .
- Kucharska M, Inglot M, Szymczak A, Rymer W, Zalewska M, Malyszczak K, et al. Co-infection of the hepatitis C virus with other blood-borne and hepatotropic viruses among hemophilia patients in Poland. Hepat Mon. 2016; 16: e35658 10.5812/hepatmon.35658 .
- de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, et al. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates. J Clin Virol. 2006; 35: 244–249. Epub 2005 Sep 6. 10.1016/j.jcv.2005.06.006 .
- Caterino-de-Araujo A, Alves FA, Campos KR, Lemos MF, Moreira RC. Making the invisible visible: searching for human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in Brazilian patients with viral hepatitis B and C. Mem Inst Oswaldo Cruz. 2018; 113: 130–134. 10.1590/0074-02760170307 .
- Maciel AM, Mello CE. Hepatitis C virus and Human T-cell lymphotropic virus co- infection: an epidemiological, clinical and laboratory analysis. Arch Clin Microbiol. 2015; 6: 1–7.
- Pinto MT, Rodrigues ES, Malta TM, Azevedo R, Takayanagui OM, Valente VB, et al. HTLV-1/2 seroprevalence and coinfection rate in Brazilian first-time blood donors: an 11-year follow-up. Rev Inst Med Trop Sao Paulo. 2012; 54: 123–129. 10.1590/s0036-46652012000300002 .
- Bahia F, Novais V, Evans J, Le Marchand C, Netto E, Page K, et al. The impact of human T-cell lymphotropic virus I infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus. J Acquir Immune Defic Syndr. 2011; 57: S202–S207. 10.1097/QAI.0b013e31821e9a1e .
- Abad-Fernández M, Moreno A, Dronda F, del Campo S, Quereda C, Casado JL, et al. Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy. AIDS. 2015; 29: 401–409. 10.1097/QAD.0000000000000555 .
- Silva MC, Silva CA, Machado GU, Atta A, S MF, Carvalho E, et al. HCV/HTLV coinfection: Does HTLV-1 interfere in the natural history of HCV-related diseases? J Med Virol. 2016; 88: 1967–1972. Epub 2016 Apr 22. 10.1002/jmv.24538 .
- Espíndola OM, Vizzoni AG, Lampe E, Andrada-Serpa MJ, Araujo AQ, Leite AC. Hepatitis C virus and human T-cell lymphotropic virus type 1 co-infection: impact on liver disease, virological markers, and neurological outcomes. Int J Infect Dis. 2017; 57: 116–122. Epub 2017 Feb 7. 10.1016/j.ijid.2017.01.037 .
- Kamihira S, Momita S, Ikeda S, Yamada Y, Sohda H, Atogami S, et al. Cohort study of hepatotropic virus and human T lymphotropic virus type-I infections in an area endemic for adult T cell leukemia. Jpn J Med. 1991; 30: 492–497. 10.2169/internalmedicine1962.30.492 .
- Kishihara Y, Furusyo N, Kashiwagi K, Mitsutake A, Kashiwagi S, Hayashi J. Human T lymphotropic virus type 1 infection influences hepatitis C virus clearance. J Infect Dis. 2001; 184: 1114–1119. Epub 2001 Sep 21. 10.1086/323890 .
- Hisada M, Chatterjee N, Zhang M, Battjes RJ, Goedert JJ. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II. J Infect Dis. 2003; 188: 891–897. Epub 2003 Sep 9. 10.1086/377585 .
- Tokunaga M, Uto H, Oda K, Tokunaga M, Mawatari S, Kumagai K, et al. Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Gastroenterol. 2014; 49: 1567–1577. Epub 2014 Jan 25. 10.1007/s00535-013-0928-5 .
- Dourado I, Alcantara LC, Barreto ML, da Gloria Teixeira M, Galvão-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr. 2003; 34: 527–531. 10.1097/00126334-200312150-00013 .
- Brito V da S, Santos FLN, Gonçalves NLS, Araujo TH, Nascimento DSV, Pereira FM, et al. Performance of commercially available serological screening tests for human T-cell lymphotropic virus infection in Brazil. J Clin Microbiol. 2018; pii: e00961–18. 10.1128/JCM.00961-18 .
- Naz A, Mukry SN, Naseer I, Shamsi TS. Evaluation of efficacy of serological methods for detection of HCV infection in blood donors: A single centre experience. Pakistan J Med Sci. 2018; 34: 1204–1208. 10.12669/pjms.345.15707 .
- Moreira M, Ramos A, Netto EM, Brites C. Characteristics of co-infections by HCV and HBV among Brazilian patients infected by HIV-1 and/or HTLV-1. Braz J Infect Dis. 2013; 17: 661–666. Epub 2013 Sep 9. 10.1016/j.bjid.2013.04.009 .
- Milagres FA, Duarte MI, Viso AT, Segurado AC. Hepatitis C virus and human T-lymphotropic virus coinfection: epidemiological, clinical, laboratory and histopathological features. Rev Soc Bras Med Trop. 2009; 42: 363–368. 10.1590/s0037-86822009000400001 .
- Prati D. Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol. 2006; 45: 607–616. Epub 2006 Jul 25. 10.1016/j.jhep.2006.07.003 .
- Caterino-de-Araujo A, Sacchi CT, Goncalves MG, Campos KR, Magri MC, Alencar WK, et al. Short Communication: current prevalence and risk factors associated with human T lymphotropic virus type 1 and human T lymphotropic virus type 2 infections among HIV/AIDS patients in São Paulo, Brazil. AIDS Res Hum Retroviruses. 2015; 31: 543–549. Epub 2015 Jan 2. 10.1089/AID.2014.0287 .
- Oliveira-Filho AB, Sawada L, Pinto LC, Locks D, Bahia SL, Castro JA, et al. Epidemiological aspects of HCV infection in non-injecting drug users in the Brazilian state of Para, eastern Amazon. Virol J. 2014; 11: 38 10.1186/1743-422X-11-38 .
- Alter M. Epidemiology of hepatitis C virus infection. World J Gastroenterol. 2007; 13: 2436–2441. 10.3748/wjg.v13.i17.2436 .
- Cardoso DF, Souza FV, Fonseca LA, Duarte AJ, Casseb J. Influence of human T-cell lymphotropic virus type 1 (HTLV-1) Infection on laboratory parameters of patients with chronic hepatitis C virus. Rev Inst Med Trop São Paulo. 2009; 51: 325–329. 10.1590/s0036-46652009000600003 .
- Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology. 2002; 36: S99–S105. 10.1053/jhep.2002.36797 .
- Ishak R, Harrington WJ Jr., Azevedo VN, Eiraku N, Ishak MO, Guerreiro JF, et al. Identification of human T cell lymphotropic virus type IIa infection in the Kayapo, an indigenous population of Brazil. AIDS Res Hum Retroviruses. 1995; 11: 813–821. 10.1089/aid.1995.11.813 .
- Le Marchand C, Bahia F, Page K, Brites C. Hepatitis C virus infection and spontaneous clearance in HTLV-1 and HIV co-infected patients in Salvador, Bahia, Brazil. Braz J Infect Dis. 2015; 19: 486–491. Epub 2015 Aug 5. 10.1016/j.bjid.2015.06.007 .
- Ministério da Saúde do Brasil. Boletim Epidemiológico—Hepatites virais. Brasília: Ministério da Saúde; 2018. Available: .
- Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015; 61: 77–87. Epub 2014 Jul 28 10.1002/hep.27259 .
- Petruzziello A, Marigliano S, Loquercio G, Cacciapuoti C. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infect Agent Cancer. 2016; 11: 53 10.1186/s13027-016-0099-0 .
Source: PubMed